amifostine anhydrous has been researched along with adenosine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Akbulut, S; Bayraktar, N; Dagdeviren, A; Karakayali, H; Oksuz, E; Sevmis, S; Unlukaplan, M | 1 |
1 review(s) available for amifostine anhydrous and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for amifostine anhydrous and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions.
Topics: Adenosine; Alanine Transaminase; Alkaline Phosphatase; Allopurinol; Amifostine; Animals; Antioxidants; Apoptosis; Biomarkers; Biopsy; Cold Ischemia; Cytoprotection; Drug Synergism; Glucose; Glutathione; Hepatectomy; In Situ Nick-End Labeling; Insulin; Liver; Male; Mannitol; Microscopy, Electron, Transmission; Models, Animal; Nitric Oxide; Nitric Oxide Synthase Type II; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Rats, Sprague-Dawley; Time Factors | 2014 |